A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas.

被引：0
|
作者：
Buckstein, Rena
Crump, Michael
Fraser, Graeme A.
Cheung, Matthew C.
Piliotis, Eugenia
Imrie, Kevin
Kukreti, Vishal
Kuruvilla, John
Meyer, Ralph M.
Windsor, Jolanta
Pond, Gregory Russell
Pritchard, Kathleen I.
Levine, Mark Norman
机构：
[1] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Princess Margaret Canc Ctr, Univ Hlth Network, Toronto, ON, Canada
[5] Juravinski Canc Ctr, Hamilton, ON, Canada
[6] McMaster Univ, Ontario Clin Oncol Grp, Hamilton, ON, Canada
[7] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[8] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.8551
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8551
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Peripheral T-Cell Lymphomas
    Macon, William R.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (04) : 829 - +
  • [32] Peripheral T-cell lymphomas
    Broccoli, Alessandro
    Zinzani, Pier Luigi
    HEMATOLOGICAL ONCOLOGY, 2023, 41 : 82 - 87
  • [33] Peripheral T-cell lymphomas
    Tournilhac, Olivier
    Delarue, Richard
    Gaulard, Philippe
    HEMATOLOGIE, 2014, 20 (05): : 284 - 294
  • [34] Hepatosplenic αβ T-cell lymphomas:: A report of four cases with features similar to hepatosplenic γδ T-cell lymphomas.
    Macon, WR
    Levy, NB
    Casey, TT
    Salhany, KE
    Park, JP
    Cousar, JB
    MODERN PATHOLOGY, 1998, 11 (01) : 135A - 135A
  • [35] PERIPHERAL T-CELL LYMPHOMAS
    FELLER, AC
    LENNERT, K
    ZWINGERS, T
    HISTOPATHOLOGY, 1991, 19 (05) : 481 - 482
  • [36] Peripheral T-cell lymphomas
    Savage, Kerry J.
    BLOOD REVIEWS, 2007, 21 (04) : 201 - 216
  • [37] Identical T-cell clone in skin and peripheral blood is an independent prognostic factor in primary cutaneous T-cell lymphomas.
    Merlio, JP
    Beylot-Barry, M
    Sibaud, V
    Thiebaut, R
    Vergier, B
    Beylot, CP
    Delaunay, MM
    Chene, G
    Dubus, P
    BLOOD, 2000, 96 (11) : 128A - 128A
  • [38] Peripheral non-cutaneous T-cell lymphomas.: A clinicopathologic study of 29 cases
    Salar, A
    de Sevilla, AF
    Romagosa, V
    Domingo-Claros, A
    González-Barca, E
    Grañena, A
    MEDICINA CLINICA, 1999, 112 (07): : 255 - 256
  • [39] A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas
    Weidmann, Eckhart
    Hess, Georg
    Chow, Kai U.
    Krause, Stefan W.
    Subklewe, Marion
    Kruse, Judith
    Weisel, Katja C.
    Soekler, Martin
    Kim, Soo-Zin
    Napieralski, Simone
    Rech, Juergen
    Dreyling, Martin
    Jaeger, Elke
    Mitrou, Paris S.
    LEUKEMIA & LYMPHOMA, 2010, 51 (03) : 447 - 455
  • [40] Dose-Adjusted EPOCH Chemotherapy for Untreated Peripheral T-Cell Lymphomas: Multicenter Phase II Trial of West-Jhog PTCL0707
    Maeda, Yoshinobu
    Nishimori, Hisakazu
    Hiramatsu, Yasushi
    Yoshida, Isao
    Uno, Masatoshi
    Masaki, Yasufumi
    Sunami, Kazutaka
    Masunari, Taro
    Nawa, Yuichiro
    Gomyo, Hiroshi
    Yamane, Hiromichi
    Takahashi, Tsutomu
    Yano, Tomofumi
    Takimoto, Hidetaka
    Matsuo, Keitaro
    Yoshino, Tadashi
    Tanimoto, Mitsune
    BLOOD, 2016, 128 (22)
12345